Effective treatments of pain for extended periods of time are provided. The treatments include the administration of one or more drug depots intraspinally wherein the drug depots include an effective amount of baclofen formulated within a polyorthoester. By administration of one or more drug depots,
Effective treatments of pain for extended periods of time are provided. The treatments include the administration of one or more drug depots intraspinally wherein the drug depots include an effective amount of baclofen formulated within a polyorthoester. By administration of one or more drug depots, one can relieve pain caused by diverse sources, including but not limited to chronic pelvic pain syndromes, spinal disc herniation (i.e. sciatica), spondilothesis, stenosis, discongenic back pain and joint pain, as well as pain that is incidental to surgery. In some embodiments, the relief can be for at least thirty days, at least sixty days, at least one hundred days or at least one hundred and thirty-five days.
대표청구항▼
1. An implantable drug depot useful for reducing or treating pain in a patient in need of such treatment, the drug depot comprising: a polyorthoester in an amount of about 95 to 99 wt. % based on the total weight of the drug depot, the polyorthoester having a viscosity of about 500 to 10,000 centipo
1. An implantable drug depot useful for reducing or treating pain in a patient in need of such treatment, the drug depot comprising: a polyorthoester in an amount of about 95 to 99 wt. % based on the total weight of the drug depot, the polyorthoester having a viscosity of about 500 to 10,000 centipoises and prepared from trans-cylcohexanedimethanol, 1,6-hexanediol, and diethyltartrate;baclofen in an amount of about 1 to 5 wt. % based on the total weight of the drug depot and having a particle size of between about 5 μm to 50 μm; magnesium oxide; andat least one of sorbitane tristearate, sorbitane trioleate, poloxamer 407, sorbital, cyclodextrin, maltodextrin, or poloxamer 188,wherein the drug depot is adapted to be administered intraspinally in the patient to reduce or treat pain, has a modulus of elasticity in the range of about 2×104 to about 5×105 dynes/cm2 after the drug depot is administered at the site, and capable of releasing baclofen for a period of 30 to 180 days after administration; andthe polyorthoester is capable of degrading in 200 days or less after the drug depot is administered at the site. 2. An implantable drug depot according to claim 1, wherein the depot further comprises a radiographic marker. 3. An implantable drug depot according to claim 1, further comprising one or more of polyaspirin, polyphosphazene, polyanhydride; polyketal, collagen, starch, pre-gelatinized starch, hyaluronic acid, chitosan, gelatin, alginate, albumin, fibrin, vitamin E analog, d-alpha tocopheryl succinate, poly-c-caprolactone, dextran, polyvinylpyrrolidone, polyvinyl alcohol, PEGT-PBT (polyethylene terephthalate glycol-polybutylene terephthalate) copolymer, PEO-PPO-PEO (poly(ethylene oxide)-poly(propylene oxide)-poly(ethylene oxide) tri-block copolymers, sucrose acetate isobutyrate, a different polyorthoester or a combination thereof. 4. An implantable drug depot according to claim 1, wherein the baclofen is in the form of a base salt or a mixture of base salt and free base. 5. An implantable drug depot according to claim 1, wherein the drug depot is in the form of a ribbon, rod or pellet. 6. An implantable drug depot according to claim 1, wherein the drug depot releases about 0.5 mg to about 20 mg of the baclofen over a period of 30 days.
연구과제 타임라인
LOADING...
LOADING...
LOADING...
LOADING...
LOADING...
이 특허에 인용된 특허 (89)
Himmelstein Kenneth J. (Lawrence KS) Higuchi Takeru (Lawrence KS), Acid anhydrides as rate controlling agent for the erosion of polymers which latter polymers have beneficial substances d.
Kohn Joachim B. ; Bolikal Durgadas ; Brode George L. ; Ertel Sylvie I.,FRX ; Guan Shuiyun ; Kemnitzer John E., Biodegradable, anionic polymers derived from the amino acid L-tyrosine.
Caldwell Larry J. (Lawrence KS) Gardner Colin R. (Lawrence KS) Cargill Robyn C. (Lawrence KS), Drug delivery device which can be retained in the stomach for a controlled period of time.
Caldwell Larry J. (Lawrence KS) Gardner Colin R. (Lawrence KS) Cargill Robyn C. (Lawrence KS), Drug delivery device which can be retained in the stomach for a controlled period of time.
Caldwell Larry J. (Lawrence KS) Gardner Colin R. (Lawrence KS) Cargill Robyn C. (Lawrence KS) Higuchi Takeru (Lawrence KS), Drug delivery device which can be retained in the stomach for a controlled period of time.
John W. Gibson ; Stacey A. Sullivan ; John C. Middleton ; Arthur J. Tipton, High viscosity liquid controlled delivery system and medical or surgical device.
Aebischer Patrick (Barrington RI) Goddard Moses (Tiverton RI) Moldauer John G. (Brooklyn NY) Mulhauser Paul J. (New York NY) Rathbun Anne M. (Providence RI) Sanberg Paul R. (Greenwich RI) Vasconcello, Implantable therapy systems and methods.
Heller Jorge (Woodside CA) Penhale Donald W. H. (Menlo Park CA) Ng Steve Y. (San Francisco CA), Method of preparing bioerodible polymers having pH sensitivity in the acid range and resulting product.
Heller Jorge (Woodside CA) Penhale Donald W. H. (Menlo Park CA) Ng Steve Y. (San Francisco CA), Method of preparing bioerodible polymers having pH sensitivity in the acid range and resulting product.
Erik H. F. Wong ; Saeeduddin Ahmed ; Robert C. Marshall ; Robert McArthur ; Duncan P. Taylor ; Lars Birgerson ; Pasquale Cetera, Method of treating or preventing chronic pain with a highly selective norepinephrine reuptake inhibitor.
Sackler, Richard S.; Goldenheim, Paul D.; Chasin, Mark; Burch, Ronald M.; Reder, Robert F.; Tigner, Joseph, Methods for providing safe local anesthesia.
Zentner Gaylen M. (Lawrence KS) Himmelstein Kenneth J. (Irvine CA) Pogany Stefano A. (Lawrence KS) Ringeisen Cheryl (Olathe KS), Organic acids as catalysts for the erosion of polymers.
Hubbell, Jeffrey A.; Pathak, Chandrashekhar P.; Sawhney, Amarpreet S.; Desai, Neil P.; Hill, Jennifer L., Photopolymerizable biodegradable hydrogels as tissue contacting materials and controlled-release carriers.
Heller Jorge (Woodside CA) Penhale Donald W. H. (Menlo Park CA) Ng Steve Y. (San Francisco CA), Polyacetal and polyketal hydrogels formed from acetals or ketals and polyols.
Heller Jorge (Woodside CA) Ng Steve Y. W. (San Francisco CA) Penhale Donald W. H. (Menlo Park CA), Polymers containing acetal, carboxy-acetal, ortho ester and carboxyortho ester linkages.
Heller Jorge (Woodside CA) Ng Steve Y. W. (San Francisco CA) Penhale Donald W. H. (Menlo Park CA), Polymers containing carboxy-ortho ester and ortho ester linkages.
Heller Jorge (Palo Alto CA) Helwing Robert F. (Sunnyvale CA) Penhale Donald W. (Cupertino CA), Polymers of di- (and higher functionality) ketene acetals and polyols.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.